Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ONCS

OncoSec Medical (ONCS) Stock Price, News & Analysis

OncoSec Medical logo

About OncoSec Medical Stock (NASDAQ:ONCS)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.20
$0.94
52-Week Range
N/A
Volume
52.49 million shs
Average Volume
2.22 million shs
Market Capitalization
$1.26 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ONCS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for OncoSec Medical and its competitors with MarketBeat's FREE daily newsletter.

ONCS Stock News Headlines

PVCT Provectus Biopharmaceuticals, Inc.
ONCS - OncoSec Medical Incorporated
AI Meltdown Imminent: Dump These Stocks Now!
If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new invention… This could send many popular AI stocks crashing, including Nvidia. And it could happen starting as soon as June 1st.
Why Is OncoSec Medical (ONCS) Stock Up 100% Today?
See More Headlines

ONCS Stock Analysis - Frequently Asked Questions

OncoSec Medical Incorporated (NASDAQ:ONCS) posted its earnings results on Tuesday, December, 14th. The biotechnology company reported ($5.50) earnings per share for the quarter, beating the consensus estimate of ($8.14) by $2.64.

OncoSec Medical's stock reverse split on Wednesday, November 9th 2022.The 1-22 reverse split was announced on Wednesday, November 9th 2022. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, November 9th 2022. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that OncoSec Medical investors own include Cytokinetics (CYTK), Inovio Pharmaceuticals (INO), Anavex Life Sciences (AVXL), Sorrento Therapeutics (SRNE), XOMA Royalty (XOMA), Amarin (AMRN) and Catalyst Pharmaceuticals (CPRX).

Company Calendar

Last Earnings
12/14/2021
Today
7/12/2025
Fiscal Year End
7/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NASDAQ:ONCS
CIK
1444307
Employees
40
Year Founded
2011

Profitability

EPS (Trailing Twelve Months)
($15.2865)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$34.18 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-868.29%
Return on Assets
-160.61%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.89
Quick Ratio
0.89

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$3.42 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
4,550,000
Free Float
4,494,000
Market Cap
$1.26 million
Optionable
Not Optionable
Beta
1.99

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:ONCS) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners